company background image
R9U2 logo

Green Thumb Industries DB:R9U2 Stock Report

Last Price

€7.45

Market Cap

€1.8b

7D

-2.9%

1Y

-14.4%

Updated

22 Dec, 2024

Data

Company Financials +

Green Thumb Industries Inc.

DB:R9U2 Stock Report

Market Cap: €1.8b

R9U2 Stock Overview

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. More details

R9U2 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth4/6
Past Performance3/6
Financial Health4/6
Dividends0/6

Rewards

Trading at 80.4% below our estimate of its fair value

Earnings are forecast to grow 34.17% per year

Became profitable this year

Risk Analysis

Volatile share price over the past 3 months compared to the German market


My Notes

Capture your thoughts, links and company narrative

Green Thumb Industries Inc. Competitors

Dermapharm Holding

XTRA:DMP

€2.0b

PharmaSGP Holding

XTRA:PSG

€283.0m

Pierrel

DB:2FJ0

€92.8m

Merck KGaA

XTRA:MRK

€60.1b

Price History & Performance

Summary of share price highs, lows and changes for Green Thumb Industries
Historical stock prices
Current Share PriceCA$7.45
52 Week HighCA$14.40
52 Week LowCA$7.25
Beta1.36
1 Month Change-14.81%
3 Month Change-19.37%
1 Year Change-14.37%
3 Year Change-58.38%
5 Year Change-1.32%
Change since IPO46,462.50%

Recent News & Updates

Recent updates

Shareholder Returns

R9U2DE PharmaceuticalsDE Market
7D-2.9%-2.5%-2.6%
1Y-14.4%-15.6%6.9%

Return vs Industry: R9U2 exceeded the German Pharmaceuticals industry which returned -15.6% over the past year.

Return vs Market: R9U2 underperformed the German Market which returned 6.9% over the past year.

Price Volatility

Is R9U2's price volatile compared to industry and market?
R9U2 volatility
R9U2 Average Weekly Movement8.4%
Pharmaceuticals Industry Average Movement5.4%
Market Average Movement4.8%
10% most volatile stocks in DE Market11.2%
10% least volatile stocks in DE Market2.4%

Stable Share Price: R9U2's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: R9U2's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of German stocks.

About the Company

FoundedEmployeesCEOWebsite
20144,800Ben Kovlerwww.gtigrows.com

Green Thumb Industries Inc. manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States. It operates through two segments, Retail and Consumer Packaged Goods. The company offers cannabis flower; processed and packaged products, including pre-rolls, concentrates, vapes, capsules, tinctures, edibles, topicals, and other cannabis-related products under the &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RHYTHM brands.

Green Thumb Industries Inc. Fundamentals Summary

How do Green Thumb Industries's earnings and revenue compare to its market cap?
R9U2 fundamental statistics
Market cap€1.82b
Earnings (TTM)€60.97m
Revenue (TTM)€1.07b

29.8x

P/E Ratio

1.7x

P/S Ratio

Is R9U2 overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
R9U2 income statement (TTM)
RevenueUS$1.12b
Cost of RevenueUS$535.32m
Gross ProfitUS$585.73m
Other ExpensesUS$522.11m
EarningsUS$63.62m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.27
Gross Margin52.25%
Net Profit Margin5.68%
Debt/Equity Ratio14.4%

How did R9U2 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 12:56
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Green Thumb Industries Inc. is covered by 24 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Aaron GreyAlliance Global Partners
Frederico Yokota Choucair GomesATB Capital Markets
Russell StanleyBeacon Securities Limited